EGFR and neoplasm: According to the transcriptomic analysis of EGFR-mutant NSCLC tumor cells HCC827 and HCC4006 before and after the development of EGFR-TKI resistance, 380 common upregulated DEGs (logFC > 2, adjusted P < 0.01) were selected [Figure 2A].